Axitinib is used to treat advanced kidney cancer in case of failure of previous treatments.
How it works
Axitinib belongs to a class of drugs called selective tyrosine kinase inhibitors. It inhibits the growth of cancer cells by blocking the action of enzymes which are responsible for its growth and survival.
Common side effects
Vomiting, Nausea, Excessive thirst, Muscle pain, Joint pain, Constipation, Cough, Diarrhoea, Hair loss, Impaired healing, Itching, Loss of appetite, Mouth ulcer, Ringing in ear, Tachycardia, Tingling sensation of extremity, Voice change, Weakness, Weight loss
- 1 variant(s)
- Inform your doctor if you have gastrointestinal infection, ulcer, or undergone gastrointestinal surgeries.
- Discontinue the use of axitinib, 24 hours prior to a scheduled surgery.
- Your blood pressure, liver function and thyroid function will be monitored before and during axitinib treatment.
- Do not take this drug if you are allergic to Axitinib or any of its ingredients.
- Seek immediate medical attention if you suffer from bleeding problems, severe stomach pain that lasts longer, fits, changes in vision, excessive tiredness, swelling of the abdomen, legs or ankles, shortness of breath, or protruding neck veins.
Frequently asked questions
Q. Is axitinib approved by FDA?
Yes, axitinib is approved by FDA.